Back
Accenture plc - Ordinary Shares - Class A Vs. Nektar Therapeutics Industry Stock Comparison
Sell
42
ACN
Accenture plc - Ordinary Shares - Class A
Last Price:
$249.15
Seasonality Move:
4.52%
Buy
62
NKTR
Nektar Therapeutics
Last Price:
$27.39
Seasonality Move:
6.79%
Sell
42
Accenture plc - Ordinary Shares - Class A (ACN)
is a Sell
Is Accenture plc - Ordinary Shares - Class A a Buy, Sell or Hold?
-
The current Accenture plc - Ordinary Shares - Class A [ACN] share price is $247.01. The Score for ACN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ACN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $27.26. The Score for NKTR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACN Stock Price Chart
What is Accenture plc - Ordinary Shares - Class A's stock price today?
-
The Accenture plc - Ordinary Shares - Class A share price today is $247.01Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACN is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $27.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.
ACN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -12.74 | Sell |
Relative Strength Index (14 RSI): | 32.65 | Sell |
Chaikin Money Flow: | -1292498 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (247.16 - 282.7) | Sell |
Bollinger Bands (100): | (272.31 - 316.31) | Sell |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 66.02 | Buy |
Chaikin Money Flow: | -23288 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.49 - 25.51) | Buy |
Bollinger Bands (100): | (8.3 - 22.66) | Buy |
ACN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 242.97 | Buy |
20-day SMA: | 261.12 | Sell |
50-day SMA: | 284.44 | Sell |
200-day SMA: | 325.89 | Sell |
8-day EMA: | 246.63 | Buy |
20-day EMA: | 258 | Sell |
50-day EMA: | 277.22 | Sell |
200-day EMA: | 311.29 | Sell |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.13 | Buy |
20-day SMA: | 23.8 | Buy |
50-day SMA: | 20.82 | Buy |
200-day SMA: | 15.1 | Buy |
8-day EMA: | 24.9 | Buy |
20-day EMA: | 23.86 | Buy |
50-day EMA: | 21.15 | Buy |
200-day EMA: | 16.63 | Buy |
Accenture plc - Ordinary Shares - Class A Earnings Growth & ACN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.04 per share, an increase this year of $0.97 per share, and an increase next year of $0.95 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.
Accenture plc - Ordinary Shares - Class A Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |